Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin -
paclitaxel therapy.
Not exact matches
Based on results of the current study described in a report online June 18 in the journal Cancer Cell, Johns Hopkins researchers say they are planning a phase I clinical trial to test the
paclitaxel - fostamatinib combination
therapy in patients with recurrent advanced ovarian cancer.
Randomized Phase III Study of Maintenance
Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin,
Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC